Show simple item record

dc.contributor.authorDelany, C
dc.contributor.authorMcDonnell, R
dc.contributor.authorRobson, M
dc.contributor.authorCorcoran, S
dc.contributor.authorFitzpatrick, C
dc.contributor.authorDe La Harpe, D
dc.date.accessioned2013-07-16T10:31:59Z
dc.date.available2013-07-16T10:31:59Z
dc.date.issued2011-01
dc.identifier.citationFolic acid supplement use in the prevention of neural tube defects. 2011, 104 (1):12-5 Ir Med Jen_GB
dc.identifier.issn0332-3102
dc.identifier.pmid21387878
dc.identifier.urihttp://hdl.handle.net/10147/296171
dc.description.abstractIn 2008, planned folic acid fortification for the prevention of Neural Tube Defects (NTD) was postponed. Concurrently, the economic recession may have affected dietary folic acid intake, placing increased emphasis on supplement use. This study examined folic acid supplement use in 2009. A cross-sectional survey of 300 ante-natal women was undertaken to assess folic acid knowledge and use. Associations between demographic, obstetric variables and folic acid knowledge and use were examined. A majority, 284/297 (96%), had heard of folic acid, and 178/297 (60%) knew that it could prevent NTD. Most, 270/297 (91%) had taken it during their pregnancy, but only 107/297 (36%) had used it periconceptionally. Being older, married, planned pregnancy and better socioeconomic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from economic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from earlier years. Continuous promotion efforts are necessary. Close monitoring of folic acid intake and NTD rates is essential, particularly in the absence of fortification.
dc.language.isoenen
dc.publisherIrish medical journalen_GB
dc.rightsArchived with thanks to Irish medical journalen_GB
dc.subject.meshAdult
dc.subject.meshCross-Sectional Studies
dc.subject.meshDietary Supplements
dc.subject.meshFemale
dc.subject.meshFolic Acid
dc.subject.meshHealth Knowledge, Attitudes, Practice
dc.subject.meshHumans
dc.subject.meshNeural Tube Defects
dc.subject.meshPregnancy
dc.subject.meshSocioeconomic Factors
dc.subject.meshVitamin B Complex
dc.titleFolic acid supplement use in the prevention of neural tube defects.en_GB
dc.typeArticleen
dc.contributor.departmentRCSI, 123 St Stephen's Green, Dublin 2.en_GB
dc.identifier.journalIrish medical journalen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
refterms.dateFOA2018-08-23T06:16:23Z
html.description.abstractIn 2008, planned folic acid fortification for the prevention of Neural Tube Defects (NTD) was postponed. Concurrently, the economic recession may have affected dietary folic acid intake, placing increased emphasis on supplement use. This study examined folic acid supplement use in 2009. A cross-sectional survey of 300 ante-natal women was undertaken to assess folic acid knowledge and use. Associations between demographic, obstetric variables and folic acid knowledge and use were examined. A majority, 284/297 (96%), had heard of folic acid, and 178/297 (60%) knew that it could prevent NTD. Most, 270/297 (91%) had taken it during their pregnancy, but only 107/297 (36%) had used it periconceptionally. Being older, married, planned pregnancy and better socioeconomic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from economic status were associated with periconceptional use. Periconceptional folic acid use in 2009 was very low, little changed from earlier years. Continuous promotion efforts are necessary. Close monitoring of folic acid intake and NTD rates is essential, particularly in the absence of fortification.


Files in this item

Thumbnail
Name:
Article5745.pdf
Size:
11.71Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record